<DOC>
	<DOCNO>NCT01675674</DOCNO>
	<brief_summary>This study do learn many child young adult come pediatric rheumatology clinic may mucopolysaccharidosis ( MPS ) . The study test 4 type MPS : I , II , IVA , VI . This help researcher decide whether create screen program MPS pediatric rheumatology clinic . This study do rheumatology clinic first symptom MPS often joint problem stiff joint , rheumatologist may first doctor patient MPS visit . The study also evaluate utility dry blood spot test MPS .</brief_summary>
	<brief_title>Study Detect Unrecognized Mucopolysaccharidosis Children Visiting Rheumatology , Hand Skeletal Dysplasia Clinics</brief_title>
	<detailed_description>MPS , mucopolysaccharidosis ( mew-co-paw-lee-sack-a-rid-o-sis ) , disorder group rare inherit disease affect 1 every 25,000 people United States . There 7 MPS disorder : MPS I ( Hurler , Hurler-Scheie , Scheie syndromes ) , II ( Hunter syndrome ) , III ( Sanfilippo syndrome ) , IV ( Morquio syndrome ) , VI ( Maroteaux-Lamy syndrome ) , VII ( Sly syndrome ) , IX ( name ) . In people MPS , body break certain material body 's cell . These material build cell , cause problem stiff joint , misshapen bone , curl hand reduced hand function , frequent ear infection , vision hearing problem , `` thicken '' facial feature , heart problem . Getting access diagnosis treatment help make MPS easy manage ; unfortunately , people MPS may go undiagnosed many year . This study do learn many child young adult come pediatric rheumatology clinic may mucopolysaccharidosis ( MPS ) . The study test 4 type MPS : I , II , IVA , VI . This help researcher decide whether create screen program MPS pediatric rheumatology clinic . This study do rheumatology clinic first symptom MPS often joint problem stiff joint , rheumatologist may first doctor patient MPS visit . The study use dry blood spot ( DBS ) test screen type MPS . It also use survey evaluate utility convenience dry blood spot test MPS .</detailed_description>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis I</mesh_term>
	<mesh_term>Mucopolysaccharidosis II</mesh_term>
	<mesh_term>Mucopolysaccharidosis VI</mesh_term>
	<mesh_term>Mucopolysaccharidosis IV</mesh_term>
	<mesh_term>Osteochondrodysplasias</mesh_term>
	<criteria>1 . History present pediatric rheumatology , pediatric hand , skeletal dysplasia clinic least ONE `` highly suspicious '' symptom least TWO `` less suspicious '' symptom may indicative MPS disorder ( see ) : Highly suspicious symptom : characteristic facial feature hear loss corneal cloud cardiac manifestation dysostosis multiplex hepatosplenomegaly spinal cord compression hydrocephalus carpal tunnel syndrome delay mental development regression mental development Less suspicious symptom : short stature extensive Mongolian spot sleep apnea copious nasal discharge recurrent otitis medium , ear fluid drain , presence ear tubes frequent upper respiratory tract infection joint stiffness limit range motion hand problem ( Claw hand reduced hand function ) hernia ( inguinal umbilical ) abnormally shape teeth dental cyst tooth abscess 2 . Age least 6 month . 3 . Age 18 year time initial clinic presentation . 4 . Written , sign , date informed consent obtain subject ( 18 year age ) subject 's parent ( 18 ) . Written , dated , sign assent child also require center . 1 . Under 6 month age . 2 . Over 18 year age initial clinic presentation . 3 . Patients confirmation MPS disorder biochemical analysis and/or molecular biology . 4 . Patients MPS enzyme activity test ( i.e. , enzyme level test fibroblast , leukocyte , serum , blood spot ) already perform , result normal . ( Patients screen MPS urinary GAG test normal exclude study . ) 5 . Written inform consent available . 6 . Subject unwilling unable provide necessary blood spot analysis . 7 . Any condition would , opinion investigator , interfere participant 's ability provide inform consent , comply study instruction , possibly confound interpretation study result .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Mucopolysaccharidoses</keyword>
	<keyword>Prevalence</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Rheumatology</keyword>
	<keyword>Mucopolysaccharidosis I</keyword>
	<keyword>Mucopolysaccharidosis II</keyword>
	<keyword>Mucopolysaccharidosis IV</keyword>
	<keyword>Mucopolysaccharidosis VI</keyword>
</DOC>